Grochow LB - Search Results

1

Should anticancer drug doses be adjusted in the obese patient?

Baker SD, Grochow LB, Donehower RC. Baker SD, et al. Among authors: grochow lb. J Natl Cancer Inst. 1995 Mar 1;87(5):333-4. doi: 10.1093/jnci/87.5.333. J Natl Cancer Inst. 1995. PMID: 7853411 No abstract available.

2

Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.

Baker SD, Verweij J, Rowinsky EK, Donehower RC, Schellens JH, Grochow LB, Sparreboom A. Baker SD, et al. Among authors: grochow lb. J Natl Cancer Inst. 2002 Dec 18;94(24):1883-8. doi: 10.1093/jnci/94.24.1883. J Natl Cancer Inst. 2002. PMID: 12488482

3

Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamics.

Grochow LB, Noe DA, Dole GB, Rowinsky EK, Ettinger DS, Graham ML, McGuire WP, Donehower RC. Grochow LB, et al. J Natl Cancer Inst. 1989 Jan 18;81(2):124-30. doi: 10.1093/jnci/81.2.124. J Natl Cancer Inst. 1989. PMID: 2909752

4

Clinical and pharmacologic reappraisal of dichloromethotrexate.

Hantel A, Rowinsky EK, Noe DA, McGuire WP, Grochow LB, Vito BL, Ettinger DS, Donehower RC. Hantel A, et al. Among authors: grochow lb. J Natl Cancer Inst. 1988 Dec 7;80(19):1547-53. doi: 10.1093/jnci/80.19.1547. J Natl Cancer Inst. 1988. PMID: 3193470

5

Clinical pharmacology of oral and i.v. N-methylformamide: a pharmacologic basis for lack of clinical antineoplastic activity.

Rowinsky EK, Noe DA, Orr DW, Grochow LB, Ettinger DS, Donehower RC. Rowinsky EK, et al. Among authors: grochow lb. J Natl Cancer Inst. 1988 Jul 6;80(9):671-8. doi: 10.1093/jnci/80.9.671. J Natl Cancer Inst. 1988. PMID: 3373556

6

Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines.

Kaufmann SH, Peereboom D, Buckwalter CA, Svingen PA, Grochow LB, Donehower RC, Rowinsky EK. Kaufmann SH, et al. Among authors: grochow lb. J Natl Cancer Inst. 1996 Jun 5;88(11):734-41. doi: 10.1093/jnci/88.11.734. J Natl Cancer Inst. 1996. PMID: 8637027

7

Phase I and pharmacologic studies of topotecan in patients with impaired hepatic function.

O'Reilly S, Rowinsky E, Slichenmyer W, Donehower RC, Forastiere A, Ettinger D, Chen TL, Sartorius S, Bowling K, Smith J, Brubaker A, Lubejko B, Ignacio V, Grochow LB. O'Reilly S, et al. Among authors: grochow lb. J Natl Cancer Inst. 1996 Jun 19;88(12):817-24. doi: 10.1093/jnci/88.12.817. J Natl Cancer Inst. 1996. PMID: 8637048 Clinical Trial.

8

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.

Rowinsky EK, Grochow LB, Ettinger DS, Sartorius SE, Lubejko BG, Chen TL, Rock MK, Donehower RC. Rowinsky EK, et al. Among authors: grochow lb. Cancer Res. 1994 Jan 15;54(2):427-36. Cancer Res. 1994. PMID: 8275479 Clinical Trial.

9

Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole.

Hantel A, Donehower RC, Rowinsky EK, Vance E, Clarke BV, McGuire WP, Ettinger DS, Noe DA, Grochow LB. Hantel A, et al. Among authors: grochow lb. Cancer Res. 1990 Jun 1;50(11):3284-8. Cancer Res. 1990. PMID: 2334921

10

Prolonged infusion of hexamethylene bisacetamide: a phase I and pharmacological study.

Rowinsky EK, Ettinger DS, McGuire WP, Noe DA, Grochow LB, Donehower RC. Rowinsky EK, et al. Among authors: grochow lb. Cancer Res. 1987 Nov 1;47(21):5788-95. Cancer Res. 1987. PMID: 3664482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters